FIRMQUARRY / COMPANY INTELLIGENCE
['SAMSUNG BIOEPIS NL BV']
Not reported · Verified headquarters unavailable
General information
- Legal name
- ['SAMSUNG BIOEPIS NL BV']
- First / latest observed
- Oct 31, 2026 — Oct 31, 2026
One source-backed chronology
Timeline
Business change, facilities, workforce, corporate events, and government activity appear chronologically.
- GovernmentAward announced
Suministro de medicamentos biológicos con biosimilares, lote 14 Eculizumab (vía parenteral intravenosa) para el Servicio de Farmacia del Hospital Clínico Universitario de Valladolid, basado en Acuerdo Marco 2025/034, de INGESA "Suministro respetuoso con el medio ambiente de medicamentos biológicos con biosimilares"
Disclosed procurement context
Government Business
Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.
Global government business
Markets and currencies remain separate; incompatible currencies are never summed.
| Market | Disclosed value | Currency | Latest activity | Processes |
|---|---|---|---|---|
| ESP | €512.5K | EUR | Oct 30, 2026 | 1 |
Evidence and identifiers
Sources & Coverage
Technical identifiers live here, with retained official links and visible coverage limitations.
Source identifiers
- TED_ORGANISATIONN0271839C · source ↗